The present invention relates to inhibitors of DNMT containing zinc moiety
derivatives that have enhanced or unique properties as inhibitors of DNA
methyl transferases (DNMT) and their use in the treatment of DNMT related
diseases and disorders such as cancer. The said derivatives may further
act as HDAC inhibitors.